| Common Name: | STI MARINE FIRESTOP PUTTY (MPU) |
| Manufacturer: | SPECIFIED TECHNOLOGIES |
| SDS Revision Date: | 6/13/2016 |
| SDS Format: | GHS-US |
| Item Number(s): | 52ZX37, 52ZX38 |
| Manufacturer Model Number(s): |
SDS Table of Contents
Click the desired link below to jump directly to that section in the SDS.
STI(R*)
SAFETY DATA SHEET
PREPARED TO U.S. OSHA, CMA, ANSI, CANADIAN WHMIS, THE KOREAN ISHA (NOTICE
2009-68), THE JAPANESE INDUSTRIAL STANDARD JIS Z 7250:2000, MEXICAN
NOM018-STPS 2000, SPRING SINGAPORE, AND THE GLOBAL HARMONIZATION STANDARD
| 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE |  |
AND OF THE COMPANY UNDERTAKING
IDENTIFICATION OF THE MIXTURE:
TRADE/MATERIAL NAME: STI MARINE FIRESTOP PUTTY (MPU)
RELEVANT USE OF THE SUBSTANCE: FIRESTOP AND SOUND TRANSMISSION
USES ADVISED AGAINST: NONE
SUPPLIER/MANUFACTURER'S NAME (USA/CANADA):
STI MARINE: A DIVISION OF SPECIFIED TECHNOLOGIES, INC.
ADDRESS:
210 EVANS WAY,
SOMERVILLE, NEW JERSEY 08876
BUSINESS PHONE: (908) 526-8000 (8:00AM TO 5:00PM EASTERN STANDARD TIME)
EMERGENCY PHONE:
U.S., CANADA: 1-800-255-3924 (24 HRS)
INTERNATIONAL: +1-813-248-0585 (COLLECT-24 HRS)
SUPPLIER/IMPORTER'S NAME (ASIA):
ADDRESS:
BUSINESS PHONE:
EMAIL OF COMPETENT PERSON FOR INFORMATION ON SDS: TECHSERV@STIMARINE.COM
NOTE:
ALL UNITED STATES OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION STANDARD
(29 CFR 1910.1200), U.S. STATE EQUIVALENT STANDARDS, CANADIAN WHMIS
[CONTROLLED PRODUCTS REGULATIONS], MEXICAN NOM018-STPS 2000, SPRING
SINGAPORE, AND JAPANESE JIS Z7250 REQUIRED INFORMATION IS INCLUDED IN
APPROPRIATE SECTIONS BASED ON THE U.S. ANSI Z400.1-2010 FORMAT. THIS
PRODUCT HAS BEEN CLASSIFIED IN ACCORDANCE WITH THE HAZARD CRITERIA OF THE
COUNTRIES LISTED ABOVE.
| 2. HAZARD IDENTIFICATION | |
GLOBAL HARMONIZATION AND JAPANESE JIS Z7253 LABELING AND CLASSIFICATION:
THIS PRODUCT HAS BEEN CLASSIFIED PER UN GHS STANDARDS UNDER U.S., JAPANESE
AND OTHER APPLICABLE REGULATIONS THAT REQUIRE GLOBAL HARMONIZATION
COMPLIANCE.
CLASSIFICATION:
CARCINOGENIC CATEGORY 2, GERM CELL MUTAGEN CATEGORY 2, ACUTE DERMAL
TOXICITY CATEGORY 5, EYE IRRITATION CATEGORY 2A, SKIN IRRITATION
CATEGORY 2, SKIN SENSITIZATION CATEGORY 1, SPECIFIC TARGET ORGAN TOXICITY
REPEATED EXPOSURE CATEGORY 2
SIGNAL WORD: WARNING
HAZARD STATEMENTS:
H351: SUSPECTED OF CAUSING CANCER.
H341: SUSPECTED OF CAUSING GENETIC EFFECTS.
H313: MAY BE HARMFUL IN CONTACT WITH SKIN.
H315: CAUSES SKIN IRRITATION.
H317: MAY CAUSE AN ALLERGIC SKIN REACTION.
H319: CAUSES SERIOUS EYE IRRITATION.
H373: MAY CAUSE DAMAGE TO ORGANS THROUGH PROLONGED OR REPEATED EXPOSURE.
PRECAUTIONARY STATEMENTS:
PREVENTION:
P201: OBTAIN SPECIAL INSTRUCTIONS BEFORE USE.
P202:
DO NOT HANDLE UNTIL ALL SAFETY PRECAUTIONS HAVE BEEN READ AND UNDERSTOOD.
P260: DO NOT BREATHE VAPORS/FUME.
P271: USE ONLY OUTDOORS OR IN A WELL-VENTILATED AREA.
P272:
CONTAMINATED WORK CLOTHING SHOULD NOT BE ALLOWED OUT OF THE WORKPLACE.
P280:
WEAR PROTECTIVE GLOVES, CLOTHING, EYE PROTECTION AND FACE PROTECTION.
RESPONSE:
P308 + P313:
IF EXPOSED OR CONCERNED: GET MEDICAL ADVICE/ATTENTION.
P305 + P351 + P338:
IF IN EYES:
RINSE CAUTIOUSLY WITH WATER FOR SEVERAL MINUTES. REMOVE CONTACT LENSES, IF
PRESENT AND EASY TO DO.
P337 + P313:
IF EYE IRRITATION PERSISTS: GET MEDICAL ADVICE/ATTENTION.
P302 + P352:
IF ON SKIN: WASH WITH PLENTY OF SOAP AND WATER.
P333 + P313:
IF SKIN IRRITATION OR RASH OCCURS: GET MEDICAL ADVICE/ATTENTION.
P312: CALL A POISON CENTER OR DOCTOR IF YOU FEEL UNWELL.
P362 + P364: TAKE OFF CONTAMINATED CLOTHING AND WASH IT BEFORE REUSE.
P321: SPECIFIC TREATMENT (REMOVE FROM EXPOSURE AND TREAT SYMPTOMS).
STORAGE:
P403 + P233 + P405:
STORE IN A WELL-VENTILATED PLACE. KEEP CONTAINER TIGHTLY CLOSED. STORE
LOCKED UP.
DISPOSAL:
P501:
DISPOSE OF CONTENTS/CONTAINERS IN ACCORDANCE WITH ALL LOCAL, REGIONAL,
NATIONAL AND INTERNATIONAL REGULATIONS.
HAZARD SYMBOLS:
GHS07: EXCLAMATION MARK
GHS08: HEALTH HAZARD
KOREAN ISHA (NOTICE 2009-68) LABELING AND CLASSIFICATION:
CLASSIFIED IN ACCORDANCE WITH ISHA NOTICE 2009-68. UNDER ISHA, NO
DIFFERENCES IN CLASSIFICATION ARE APPLICABLE.
| 3. COMPOSITION AND INFORMATION ON INGREDIENTS | |
LABEL ELEMENTS
CHEMICAL NAME CAS # WT%
ALUMINUM TRIHYDRATE 21645-51-2 50-60%
PROPRIETARY POLYMER 20-30%
FORMALDEHYDE POLYMER WITH 35297-54-2 10-15%
AMMONIA AND PHENOL
PHENOL 108-95-2 1-3%
SULFURIC ACID COMPOUND 12777-87-6 2-5%
WITH GRAPHITE
CRYSTALLINE SILICA 14808-60-7 TRACE
FORMALDEHYDE 50-00-0 TRACE
WATER AND OTHER TRACE BALANCE
INGREDIENTS
CHEMICAL CHINESE JAPANESE KOREAN TAIWAN LABEL ELEMENTS
NAME IECSC ENCS # ECL # NESCI GHS & JAPANESE
INVENTORY ECS JIS Z7253
CLASSIFICATION
KOREAN ISHA
CLASSIFICATION
GHS HAZARD CODES
ALUMINUM LISTED 1-17 KE-00980 LISTED SELF
TRIHYDRATE CLASSIFICATION
GHS & JAPANESE
JIS Z7253,
KOREAN ISHA:
CLASSIFICATION:
EYE IRRITATION
CAT. 2A
HAZARD CODES:
H319
PROPRIETARY LISTED PROPRIETARY PROPRIETARY LISTED CLASSIFICATION
POLYMER NOT APPLICABLE
FORMAL- LISTED NOT LISTED KE-17082 LISTED SELF
DEHYDE CLASSIFICATION
POLYMER GHS & JAPANESE
WITH JIS Z7253,
AMMONIA KOREAN ISHA:
AND CLASSIFICATION:
PHENOL ACUTE ORAL
TOXICITY CAT. 5,
SKIN
SENSITIZATION
CAT. 1B,
STOT RE CAT. 3
HAZARD CODES:
H303, H317,
H373
PHENOL LISTED 3-381 KE-28209 LISTED GHS & JAPANESE
JIS Z7253,
KOREAN ISHA:
CLASSIFICATION:
MUTAGENIC CAT.
2, ACUTE ORAL
TOXICITY CAT. 3,
ACUTE DERMAL
TOXICITY CAT. 3,
ACUTE INHALATION
TOXICITY CAT. 3,
SKIN CORROSION
CAT. 1B, STOT RE
CAT. 2
HAZARD CODES:
H341, H301 +
H311 + H331,
H314, H373
SULFURIC NOT NOT KE-32585 LISTED SELF
ACID LISTED LISTED CLASSIFICATION:
COMPOUND GHS & JAPANESE
WITH JIS Z7253,
GRAPHITE KOREAN ISHA:
CLASSIFICATION:
CARCINOGENIC
CAT. 2
HAZARD CODES:
H351I
CRYSTALLINE LISTED 1-548 KE-29983 LISTED SELF
SILICA CLASSIFICATION:
GHS & JAPANESE
JIS Z7253,
KOREAN ISHA:
CLASSIFICATION:
CARCINOGENIC
CAT. 1, STOT
(INHALATION-
LUNGS) RE CAT. 2
HAZARD STATEMENT
CODES:
H350, H373
FORMAL- LISTED 2-482 KE-17074 LISTED GHS & JAPANESE
DEHYDE JIS Z7253,
KOREAN ISHA:
CLASSIFICATION:
CARCINOGENIC
CAT. 2, ACUTE
ORAL TOXICITY
CAT. 3, ACUTE
DERMAL TOXICITY
CAT. 3, ACUTE
INHALATION
TOXICITY CAT. 3,
SKIN CORROSION
CAT. 1B, SKIN
SENSITIZATION
CAT. 1
HAZARD CODES:
H351, H301 +
H311 + H331,
H314, H317
WATER AND CLASSIFICATION:
OTHER NOT APPLICABLE
TRACE
INGREDIENTS
SEE SECTION 16 FOR FULL TEXT OF CLASSIFICATION
| 4. FIRST-AID MEASURES | |
DESCRIPTION OF FIRST AID MEASURES:
SKIN EXPOSURE:
IF ADVERSE SKIN EFFECTS OCCUR, DISCONTINUE USE AND FLUSH CONTAMINATED
AREA. SEEK MEDICAL ATTENTION IF ADVERSE EFFECT OCCURS AFTER FLUSHING.
INHALATION:
IF FUMES OR VAPORS ARE INHALED, REMOVE VICTIM TO FRESH AIR. SEEK MEDICAL
ATTENTION IF ADVERSE EFFECT CONTINUES AFTER REMOVAL TO FRESH AIR.
EYE EXPOSURE:
IF THIS PRODUCT CONTAMINATES THE EYES, RINSE EYES UNDER GENTLY RUNNING
WATER. REMOVE CONTACT LENSES IF EASY TO DO. USE SUFFICIENT FORCE TO OPEN
EYELIDS AND THEN "ROLL" EYES WHILE FLUSHING. MINIMUM FLUSHING IS FOR
20 MINUTES. THE CONTAMINATED INDIVIDUAL MUST SEEK MEDICAL ATTENTION IF
ANY ADVERSE EFFECT CONTINUES AFTER RINSING.
INGESTION:
IF THIS PRODUCT IS SWALLOWED, CALL PHYSICIAN OR POISON CONTROL CENTER FOR
MOST CURRENT INFORMATION. IF PROFESSIONAL ADVICE IS NOT AVAILABLE, DO NOT
INDUCE VOMITING. NEVER INDUCE VOMITING OR GIVE DILUENTS (MILK OR WATER) TO
SOMEONE WHO IS UNCONSCIOUS, HAVING CONVULSIONS, OR UNABLE TO SWALLOW. IF
VICTIM IS CONVULSING, MAINTAIN AN OPEN AIRWAY AND OBTAIN IMMEDIATE MEDICAL
ATTENTION.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: SEE SECTION 11.
INDICATION OF IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT IF NEEDED:
TREAT SYMPTOMS AND ELIMINATE EXPOSURE.
| 5. FIRE-FIGHTING MEASURES | |
NFPA RATING:
HEALTH 2
FLAMMABILITY 0
INSTABILITY 0
OTHER
HAZARD SCALE:
0 = MINIMAL
1 = SLIGHT
2 = MODERATE
3 = SERIOUS
4 = SEVERE
FLASH POINT: NOT DETERMINED.
AUTOIGNITION TEMPERATURE: NOT AVAILABLE.
FLAMMABLE LIMITS (IN AIR BY VOLUME, %): NOT APPLICABLE.
FIRE EXTINGUISHING MEDIA:
USE EXTINGUISHING MATERIALS SUITABLE FOR THE SURROUNDING AREA.
UNSUITABLE FIRE EXTINGUISHING MEDIA: NONE KNOWN.
UNUSUAL FIRE AND EXPLOSION HAZARDS:
THIS PRODUCT IS FORMULATED TO BE NON-FLAMMABLE AND NON-COMBUSTIBLE.
WHEN INVOLVED IN A FIRE, THIS MATERIAL MAY DECOMPOSE AND PRODUCE
IRRITATING VAPORS AND TOXIC GASES
EXPLOSION SENSITIVITY TO MECHANICAL IMPACT: NOT SENSITIVE.
EXPLOSION SENSITIVITY TO STATIC DISCHARGE: NOT SENSITIVE.
SPECIAL PROTECTIVE ACTIONS FOR FIRE-FIGHTERS:
NO SPECIAL PROTECTIVE ACTIONS FOR FIRE-FIGHTERS ARE ANTICIPATED.
| 6. ACCIDENTAL RELEASE MEASURES | |
PERSONAL PRECAUTIONS AND EMERGENCY PROCEDURES:
UNCONTROLLED RELEASES SHOULD BE RESPONDED TO BY TRAINED PERSONNEL USING
PRE-PLANNED PROCEDURES. PROPER PROTECTIVE EQUIPMENT SHOULD BE USED. CALL
CHEMTREC (1800-424-9300) FOR EMERGENCY ASSISTANCE. OR IF IN CANADA, CALL
CANUTEC (613-996-6666).
PERSONAL PROTECTIVE EQUIPMENT: PROPER PROTECTIVE EQUIPMENT SHOULD BE USED.
SMALL SPILLS: WEAR RUBBER GLOVES.
LARGE SPILLS:
MINIMUM PERSONAL PROTECTIVE EQUIPMENT SHOULD BE RUBBER GLOVES, RUBBER
BOOTS, FACE SHIELD.
METHODS FOR CLEAN-UP AND CONTAINMENT:
SPILLS OF THIS PRODUCT PRESENT MINIMAL HAZARD.
SMALL SPILLS:
SMALL RELEASES CAN BE CAREFULLY SWEPT UP OR CLEANED UP USING A DAMP SPONGE
OR POLYPADS.
LARGE SPILLS:
ACCESS TO THE SPILL AREA SHOULD BE RESTRICTED. FOR LARGE SPILLS, DIKE OR
OTHERWISE CONTAIN SPILL AND SWEEP-UP OR VACUUM WITH NON-SPARKING VACUUM.
ALL SPILLS:
PLACE ALL SPILL RESIDUE IN A DOUBLE PLASTIC BAG OR OTHER CONTAINMENT AND
SEAL. CLOSE OFF SEWERS AND TAKE OTHER MEASURES TO PROTECT HUMAN HEALTH AND
THE ENVIRONMENT AS NECESSARY. RINSE AREA WITH SOAP AND WATER SOLUTION AND
FOLLOW WITH A WATER RINSE.
ENVIRONMENTAL PRECAUTIONS: AVOID RELEASE TO THE ENVIRONMENT.
| 7. HANDLING AND USE | |
PRECAUTIONS FOR SAFE HANDLING:
AS WITH ALL CHEMICALS, AVOID GETTING THIS MATERIAL ON YOU OR IN YOU. DO
NOT EAT, DRINK, SMOKE, OR APPLY COSMETICS WHILE HANDLING THIS PRODUCT.
WASH HANDS THOROUGHLY AFTER HANDLING THIS PRODUCT OR CONTAINERS OF THIS
PRODUCT. AVOID BREATHING FUMES OR VAPORS. USE IN A WELL-VENTILATED
LOCATION.
CONDITIONS FOR SAFE STORAGE:
STORE CONTAINERS IN A COOL, DRY LOCATION, AWAY FROM DIRECT SUNLIGHT,
SOURCES OF INTENSE HEAT.
SPECIFIC END USE(S):
THIS PRODUCT IS FOR USE AS A SEALANT. FOLLOW ALL INDUSTRY STANDARDS FOR USE
OF THIS PRODUCT.
PROTECTIVE PRACTICES DURING MAINTENANCE OF CONTAMINATED EQUIPMENT:
FOLLOW PRACTICES INDICATED IN SECTION 6 (ACCIDENTAL RELEASE MEASURES).
MAKE CERTAIN THAT APPLICATION EQUIPMENT IS LOCKED AND TAGGED-OUT SAFELY,
IF NECESSARY. COLLECT ALL RINSATES AND DISPOSE OF ACCORDING TO APPLICABLE
FEDERAL, STATE, AND LOCAL PROCEDURES.
| 8. EXPOSURE CONTROLS - PERSONAL PROTECTION | |
EXPOSURE LIMITS/CONTROL PARAMETERS:
VENTILATION AND ENGINEERING CONTROLS:
USE WITH ADEQUATE VENTILATION TO ENSURE EXPOSURE LEVELS ARE MAINTAINED
BELOW THE LIMITS PROVIDED BELOW (IF APPLICABLE). EXHAUST DIRECTLY TO THE
OUTSIDE, TAKING NECESSARY PRECAUTIONS FOR ENVIRONMENTAL PROTECTION.
WORKPLACE EXPOSURE LIMITS/CONTROL PARAMETERS:
CHEMICAL NAME CAS # EXPOSURE LIMITS IN AIR
ACGIH-TLVS OSHA-PELS
TWA STEL TWA STEL
MG/M3 MG/M3 MG/M3 MG/M3
ALUMINUM TRIHYDRATE 21645-51-2 NE NE NE NE
CRYSTALLINE SILICA 14808-60-7 0.025 NE 30 MG/M3 (TOTAL
(QUARTZ) (RESP. DUST) / % SO2 + 2
FRACT.)
0.1 (VACATED 1989
PEL)
250 MPPCF (RESP.
DUST) / % SiO2 + 5
OR
10 MG/M3 (RESP.
DUST) / 0.2 %
SO2 + 2
FORMALDEHYDE 50-00-0 SEN 0.37 0.75 PPM 2 PPM
(CEILING)
SEE 20 CFR
NIC: D-SEN, RSEN 1910.1048(C)
FORMALDEHYDE 35297-54-2 NE NE NE NE
POLYMER WITH
AMMONIA AND
PHENOL
PHENOL 108-95-2 19 (SKIN) SKIN 19 (SKIN) SKIN
PROPRIETARY POLYMER NE NE NE NE
SULFURIC ACID 12777-87-6 NE NE NE NE
COMPOUND WITH
GRAPHITE
CHEMICAL NAME EXPOSURE LIMITS IN AIR
NIOSH-RELS NIOSH OTHER
TWA STEL IDLH MG/M3
MG/M3 MG/M3 MG/M3
ALUMINUM TRIHYDRATE NE NE NE DFG MAKS:
TWA:
4 MG/M3 (INHALABLE
FRACTION)
1.5 MG/M3 (RESPIRABLE
FRACTION)
DFG MAK PREGNANCY RISK
CLASSIFICATION: D
CRYSTALLINE SILICA 0.05 NE 50, Ca CARCINOGEN:
(QUARTZ) (RESP. IARC-1, MAK-1
DUST) (RESPIRABLE FRACTION),
NOSH-CA, NTP-K
(RESPIRABLE FRACTION),
TLV-A2
FORMALDEHYDE 0.016 PPM 0.1 PPM, 20 PPM DFG MAKS:
15 MIN. (Ca) TWA: 0.37
SEE POCKET GUIDE PEAK:
APP. A 2xMAK 15-MIN AVERAGE
VALUE, 1-HR INTERVAL,
4 PER SHIFT
1 (CEILING) DANGER OF
SENSITIZATION OF THE
SKIN
DFG MAK GERM CELL
MUTAGEN CATEGORY: 5
DFG MAK PREGNANCY RISK
CLASSIFICATION: C
CARCINOGEN:
EPA-B1, IARC-1, MAK-4,
NIOSH-CA, NTP-K,
OSHA-CA, TLV-A2
FORMALDEHYDE NE NE NE NE
POLYMER WITH
AMMONIA AND
PHENOL
PHENOL 19 (SKIN) 60 (SKIN) 25 PPM DFG MAK: SKIN
15 MIN.
CARCINOGEN:
EPA-I, EPA-D, IARC-3,
MAK-3B, TLV-A4
PROPRIETARY POLYMER NE NE NE NE
SULFURIC ACID NE NE NE NE
COMPOUND WITH
GRAPHITE
NE: NOT ESTABLISHED.
CA: CARCINOGEN
NIC: NOTICE OF INTENDED CHANGE
DSEN:
MAY CAUSE DERMAL SENSITIZATION. THIS NOTATION IS USED TO INDICATE THE
POTENTIAL FOR DERMAL SENSITIZATION RESULTING FROM THE INTERACTION OF AN
ABSORBED AGENT AND ULTRAVIOLET LIGHT (I.E. PHOTOSENSITIZATION)
RSEN: MAY CAUSE RESPIRATORY SENSITIZATION
SEN:
CONFIRMED POTENTIAL WORKER SENSITIZATION AS A RESULT OF DERMAL CONTACT
AND/OR INHALATION EXPOSURE, BASED ON THE WEIGHT OF SCIENTIFIC EVIDENCE
SEE SECTION 16 FOR DEFINITIONS OF OTHER TERMS USED
INTERNATIONAL OCCUPATIONAL EXPOSURE LIMITS:
CURRENTLY, THE FOLLOWING ADDITIONAL EXPOSURE LIMIT VALUES HAVE BEEN
ESTABLISHED BY VARIOUS COUNTRIES FOR THE COMPONENTS OF THIS MIXTURE. MORE
CURRENT LIMITS MAY BE AVAILABLE; INDIVIDUAL COUNTRIES SHOULD BE CONSULTED
TO DETERMINE IF NEWER LIMITS ARE AVAILABLE.
ALUMINUM HYDROXIDE:
AUSTRALIA:
TWA: 2 MG(AL)/M3, JUL 2008
BELGIUM:
TWA: 2 MG(Al)/M3, MAR 2002
FINLAND:
TWA: 2 MG(Al)/M3, NOV 2011
FRANCE:
VME: 2 MG(Al)/M3, FEB 2006
KOREA:
TWA: 2 MG(Al)/M3, 2006
NEW ZEALAND:
TWA: 2 MG(Al)/M3, JAN 2002
RUSSIA:
TWA: 6 MG/M3, JUN 2003
SWEDEN:
TWA: 1 MG(Al)/M3, JUN 2005
SWITZERLAND:
MAK-W: 3 MG/M3, RESP, JAN 2011
UNITED KINGDOM:
TWA: 2 MG(Al)/M3, OCT 2007
IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, SINGAPORE, VIETNAM CHECK
ACGIH TLV
CRYSTALLINE SILICA:
AUSTRALIA:
TWA: 0.1 MG/M3, JUL 2008
BELGIUM:
TWA: 0.1 MG/M3 (RESP. DUST), MAR 2002
DENMARK:
TWA: 0.1 MG/M3 (RESPIRABLE), CARC, MAY 2011
DENMARK:
TWA: 0.1 MG/M3 (RESP.), CARC, MAY2011
DENMARK:
TWA: 0.3 MG/M3 (TOTAL), MAY 2011
FINLAND:
TWA: 0.05 MG/M3, RESP. DUST, SEP 2009
FRANCE:
VME: 0.1 MG/M3, (RESP), FEB 2006
ICELAND:
TWA: 0.1 MG/M3 (RESP. DUST), NOV 2011
JAPAN:
OEL-C: 0.03 MG/M3 (RESPIRABLE), APR 2007
KOREA:
TWA: 0.1 MG/M3, 2006
MEXICO:
TWA: 0.1 MG/M3 (RESPIRABLE), 2004
THE NETHERLANDS:
MAC-TGG: 0.075 MG/M3, 2003
NEW ZEALAND:
TWA: 0.2 MG/M3 (RESPIRABLE DUST), JAN 2002
NORWAY:
TWA: 0.1 MG/M3 (RESP. DUST), JAN 1999
NORWAY:
TWA: 0.3 MG/M3 (TOTAL DUST), JAN 1999
PERU:
TWA: 0.05 MG/M3, JUL 2005
RUSSIA:
TWA: 1 MG/M3
STEL: 3 MG/M3, JUN 2003
SWEDEN:
TWA: 0.1 MG/M3 (RESP. DUST), JUN 2005
SWITZERLAND:
MAK-W: 0.15 MG/M3, DEC 2006
THAILAND:
TWA: 10 MG/M3 (RESP. DUST), JAN 1993
THAILAND:
TWA: 30 MG/M3 (TOTAL DUST), JAN 1993
UNITED KINGDOM:
TWA: 0.1 MG/M3 (RESP. DUST), OCT 2007
IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, SINGAPORE, VIETNAM CHECK
ACGIH TLV
FORMALDEHYDE:
ARAB REPUBLIC OF EGYPT:
TWA: 2 PPM (3 MG/M3), JAN 1993
AUSTRALIA:
TWA: 1 PPM (1.2 MG/M3)
STEL: 2 PPM (2.5 MG/M3), CARCINOGEN, JUL 2008
AUSTRIA:
MAK-TMW: 0.5 PPM (0.6 MG/M3)
KZW: 0.5 PPM (0.6 MG/M3), SKIN, SEN, 2007
BELGIUM:
STEL: 0.3 PPM (0.38 MG/M3), MAR 2002
DENMARK:
CL: 0.3 PPM (0.4 MG/M3), CARC, MAY 2011
FINLAND:
TWA: 0.3 PPM (0.37 MG/M3)
CL: 1 PPM (1.2 MG/M3), NOV 2011
FRANCE:
VME: 0.5 PPM, VLE 1 PPM, C3 CARCINOGEN, FEB 2006
GERMANY:
MAK: 0.3 PPM (0.37 MG/M3), 2011
HUNGARY:
TWA: 0.6 MG/M3
STEL: 0.6 MG/M3, SKIN, SEP 2000
ICELAND:
TWA: 0.3 PPM (0.4 MG/M3)
STEL: 1 PPM (1.2 MG/M3), SEN, NOV 2011
JAPAN:
OEL: 0.1 PPM (0.12 MG/M3), 2A CARC, A2 SEN, S1 SEN, MAY 2012
JAPAN:
OEL: 0.2 PPM (0.24 MG/M3), MAY 2012
KOREA:
TWA: 1 PPM (1.5 MG/M3)
STEL: 2 PPM (3 MG/M3), 2006
MEXICO:
PEAK: 2 PPM (3 MG/M3), 2004
THE NETHERLANDS:
MAC-TGG: 1.5 MG/M3, 2003
NEW ZEALAND:
CL: 1 PPM (1.2 MG/M3), SEN, JAN 2002
NORWAY:
TWA: 0.5 PPM (0.6 MG/M3), JAN 1999
PERU:
TWA STEL: 0,3 PPM (0,37 MG/M3), JUL 2005
THE PHILIPPINES:
TWA: 5 PPM (6 MG/M3), JAN 1993
POLAND:
MAC(TWA): 0.5 MG/M3
MAC(STEL): 1 MG/M3, JAN 1999
RUSSIA:
STEL: 0.5 MG/M3, SKIN, JUN 2003
SWEDEN:
TWA: 0.5 PPM (0.6 MG/M3)
CL: 1 PPM (1.2 MG/M3), CARCINOGEN, SEN, JUN 2005
SWITZERLAND:
MAK-W: 0.3 PPM (0.37 MG/M3)
KZG-W: 0.6 PPM (0.74 MG/M3), CARC 3, SEN, JAN 2011
THAILAND:
TWA: 3 PPM
STEL: 5 PPM, JAN 1993
TURKEY:
TWA: 5 PPM (6 MG/M3), JAN 1993
UNITED KINGDOM:
TWA: 2 PPM (2.5 MG/M3)
STEL: 2 PPM (2.5 MG/M3), OCT 2007
IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, SINGAPORE, VIETNAM CHECK
ACGIH TLV
PHENOL:
ARAB REPUBLIC OF EGYPT:
TWA: 5 PPM (19 MG/M3), SKIN, JAN 1993
AUSTRALIA:
TWA: 1 PPM (4 MG/M3), JUL 2008
AUSTRIA:
MAK-TMW: 2 PPM (7.8 MG/M3), SKIN, 2007
DENMARK:
TWA: 2 PPM (7.8 MG/M3), SKIN, MAR 2002
DENMARK:
TWA: 1 PPM (4 MG/M3), SKIN, MAY 2011
EC:
TWA: 7.8 MG/M3 (2 PPM), SKIN, JUN 2000
FINLAND:
TWA: 2 PPM (8 MG/M3)
STEL: 4 PPM (16 MG/M3), SKIN, NOV 2011
FRANCE:
VME: 2 PPM (7.8 MG/M3), SKIN, FEB 2006
HUNGARY:
TWA: 7.8 MG/M3
STEL: 78 MG/M3, SKIN, SEP 2000
ICELAND:
TWA: 1 PPM (4 MG/M3), SKIN, NOV 2011
JAPAN:
OEL: 5 PPM (19 MG/M3), SKIN, MAY 2012
KOREA:
TWA: 5 PPM (19 MG/M3), SKIN, 2006
MEXICO:
TWA: 5 PPM (19 MG/M3)
STEL: 10 PPM (38 MG/M3) (SKIN), 2004
THE NETHERLANDS:
MAC-TGG: 8 MG/M3, SKIN, 2003
NEW ZEALAND:
TWA: 5 PPM (19 MG/M3), SKIN, JAN 2002
NORWAY:
TWA: 1 PPM (4 MG/M3), JAN 1999
PERU:
TWA: 5 PPM (19 MG/M3), JUL 2005
THE PHILIPPINES:
TWA: 5 PPM (10 MG/M3), SKIN, JAN 1993
POLAND:
MAC(TWA): 10 MG/M3
MAC(STEL): 20 MG/M3, JAN 1999
RUSSIA:
TWA: 0.3 MG/M3
STEL: 1 MG/M3, SKIN, JUN 2003
SWEDEN:
TWA: 1 PPM (4 MG/M3)
STEL: 2 PPM (8 MG/M3), SKIN, JUN 2005
SWITZERLAND:
CL: 5 PPM (19 MG/M3), SKIN, JAN 2011
THAILAND:
TWA: 5 PPM (19 MG/M3), JAN 1993
TURKEY:
TWA: 5 PPM (19 MG/M3), SKIN, JAN 1993
UNITED KINGDOM:
TWA: 2 PPM (7.8 MG/M3), SKIN, OCT 2007
IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, SINGAPORE, VIETNAM CHECK
ACGIH TLV
PROTECTIVE EQUIPMENT:
THE FOLLOWING INFORMATION ON APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT
IS PROVIDED TO ASSIST EMPLOYERS IN COMPLYING WITH OSHA REGULATIONS FOUND
IN 29 CFR SUBPART I (BEGINNING AT 1910.132, INCLUDING U.S. FEDERAL OSHA
RESPIRATORY PROTECTION (29 CFR 1910.134), OSHA EYE PROTECTION 29 CFR
1910.133, OSHA HARD PROTECTION 29 CFR 1910.138, OSHA FOOT PROTECTION
29 CFR 1910.136 AND OSHA BODY PROTECTION 29 CFR1910.132), EQUIVALENT
STANDARDS OF CANADA (INCLUDING CSA RESPIRATORY STANDARD Z94.4-02,
Z94.3-M1982, INDUSTRIAL EYE AND FACE PROTECTORS AND CSA STANDARD Z195-02,
PROTECTIVE FOOTWEAR), OR STANDARDS OF JAPAN (INCLUDING JIS T 8116:2005 FOR
GLOVE SELECTION, JIS T 8150:2006 FOR RESPIRATORY PPE, JIS T 8147:2003 FOR
EYE PROTECTORS, AND JIS T 8030:2005 FOR PROTECTIVE CLOTHING). PLEASE
REFERENCE APPLICABLE REGULATIONS AND STANDARDS FOR RELEVANT DETAILS.
RESPIRATORY PROTECTION:
MAINTAIN AIRBORNE CONTAMINANT CONCENTRATIONS BELOW EXPOSURE LIMITS LISTED
ABOVE. FOR MATERIALS WITHOUT LISTED EXPOSURE LIMITS, MINIMIZE RESPIRATORY
EXPOSURE. IF NECESSARY, USE ONLY RESPIRATORY PROTECTION AUTHORIZED UNDER
APPROPRIATE REGULATIONS.
EYE PROTECTION:
WEAR SPLASH GOGGLES OR SAFETY GLASSES AS APPROPRIATE FOR THE TASK.
HAND PROTECTION:
DURING MANUFACTURE OR OTHER SIMILAR OPERATIONS, WEAR THE APPROPRIATE HAND
PROTECTION FOR THE PROCESS.
SKIN PROTECTION:
USE APPROPRIATE PROTECTIVE CLOTHING. IF NECESSARY, REFER TO THE U.S. OSHA
TECHNICAL MANUAL (SECTION VII: PERSONAL PROTECTIVE EQUIPMENT) OR OTHER
APPROPRIATE REGULATIONS. FULL-BODY CHEMICAL PROTECTIVE CLOTHING IS
RECOMMENDED FOR EMERGENCY RESPONSE PROCEDURES.
| 9. PHYSICAL AND CHEMICAL PROPERTIES | |
FORM: PUTTY
COLOR: RED.
MOLECULAR FORMULA: MIXTURE.
MOLECULAR WEIGHT: MIXTURE.
ODOR: MINIMAL.
ODOR THRESHOLD: NOT AVAILABLE.
FLAMMABLE LIMITS (IN AIR BY VOLUME, %): NOT APPLICABLE.
OXIDIZING PROPERTIES: NOT APPLICABLE.
DECOMPOSITION TEMPERATURE: NOT AVAILABLE.
PERCENT VOLATILE: NOT AVAILABLE.
AUTOIGNITION TEMPERATURE: NOT AVAILABLE.
FLASH POINT: NOT AVAILABLE.
FREEZING/MELTING POINT: NOT AVAILABLE.
BOILING POINT: NOT AVAILABLE.
VAPOR PRESSURE: NOT AVAILABLE.
SPECIFIC GRAVITY (WATER = 1): 1.49
VAPOR DENSITY (AIR = 1): NOT AVAILABLE.
CARB VOC: NOT AVAILABLE.
EVAPORATION RATE (N-BUAC = 1): NOT APPLICABLE
SCAQMD (U.S. EPA METHOD 24): NOT AVAILABLE.
SOLUBILITY IN WATER: INSOLUBLE.
SOLUBILITY IN SOLVENTS: NOT AVAILABLE.
COEFFICIENT WATER/OIL DISTRIBUTION: NOT ESTABLISHED.
PH: NOT AVAILABLE.
HOW TO DETECT THIS SUBSTANCE (WARNING PROPERTIES IN EVENT OF ACCIDENTAL
RELEASE):
THE APPEARANCE MAY BE CHARACTERISTICS TO DISTINGUISH A RELEASE OF THIS
PRODUCT.
| 10. STABILITY AND REACTIVITY | |
CHEMICAL STABILITY:
THIS PRODUCT IS STABLE WHEN PROPERLY STORED AT NORMAL TEMPERATURE AND
PRESSURES (SEE SECTION 7, HANDLING AND STORAGE).
DECOMPOSITION PRODUCTS:
COMBUSTION:
IF EXPOSED TO EXTREMELY HIGH TEMPERATURES, THERMAL DECOMPOSITION MAY
GENERATE IRRITATING FUMES AND TOXIC GASES HYDROLYSIS: NONE KNOWN.
MATERIALS WITH WHICH SUBSTANCE IS INCOMPATIBLE:
THIS PRODUCT IS INCOMPATIBLE WITH STRONG OXIDIZERS. POSSIBILITY OF
HAZARDOUS POLYMERIZATION OR REACTION: WILL NOT OCCUR.
CONDITIONS TO AVOID:
AVOID EXPOSURE TO OR CONTACT WITH EXTREME TEMPERATURES AND INCOMPATIBLE
CHEMICALS.
| 11. TOXICOLOGICAL INFORMATION | |
HAZARDOUS MATERIAL IDENTIFICATION SYSTEM:
HEALTH HAZARD (BLUE) 2*
FLAMMABILITY HAZARD (RED) 0
PHYSICAL HAZARD(YELLOW) 0
PROTECTIVE EQUIPMENT:
EYES: CHEMICAL GOGGLES
RESPIRATORY: SEE SECTION 8
HANDS: GLOVES
BODY: SEE SECTION 8
FOR ROUTINE INDUSTRIAL USE AND HANDLING APPLICATIONS
HAZARD SCALE:
0=MINIMAL
1=SLIGHT
2=MODERATE
3=SERIOUS
4=SEVERE
*=CHRONIC HAZARD
SYMPTOMS OF EXPOSURE BY ROUTE OF EXPOSURE:
THE HEALTH HAZARD INFORMATION PROVIDED BELOW IS PERTINENT TO EMPLOYEES
USING THIS PRODUCT IN AN OCCUPATIONAL SETTING. THE FOLLOWING PARAGRAPHS
DESCRIBE THE SYMPTOMS OF EXPOSURE BY ROUTE OF EXPOSURE.
INHALATION:
INHALATION OF FUMES OR VAPORS IF HEATED MAY CAUSE IRRITATION OF THE NOSE,
THROAT, AND LUNGS AND CAUSE COUGHING. REMOVAL TO FRESH AIR SHOULD RELIEVE
SYMPTOMS. THE TRACE CRYSTALLINE SILICA AND FORMALDEHYDE COMPONENTS ARE
KNOWN HUMAN CARCINOGENS. DUE TO THE FORM OF THIS PRODUCT, THIS HAZARD IS
NOT AS SIGNIFICANT DUE TO VISCOSITY AND CONSISTENCY OF THE MIXTURE.
CONTACT WITH SKIN OR EYES:
DIRECT EYE CONTACT MAY CAUSE IRRITATION, REDNESS, AND TEARING FROM
MECHANICAL IRRITATION. PROLONGED OR REPEATED SKIN EXPOSURES MAY CAUSE
DERMATITIS (DRY RED SKIN).
SKIN ABSORPTION:
THE PHENOL COMPONENT AND TRACE FORMALDEHYDE COMPONENT CAN BE ABSORBED
THROUGH INTACT SKIN. PHENOL IN ALL FORMS (SOLID, SOLUTIONS AND VAPOR) IS
READILY ABSORBED THROUGH THE SKIN AND CAN CAUSE HARMFUL EFFECTS IF A LARGE
AREA OF THE SKIN IS INVOLVED OR IF CONTACT IS PROLONGED. DUE TO THE SMALL
AMOUNT OF EACH OF THESE MATERIALS, THE POSSIBILITY OF ADVERSE EFFECTS IS
NOT EXPECTED TO BE SIGNIFICANT HOWEVER, SKIN CONTACT SHOULD BE AVOIDED.
FORMALDEHYDE AND PHENOL CAN CAUSE SENSITIZATION EFFECTS AS DESCRIBED UNDER
'SENSITIZATION EFFECT'S'.
INGESTION:
INGESTION IS NOT A SIGNIFICANT ROUTE OF OCCUPATIONAL EXPOSURE AND IS
UNLIKELY TO OCCUR. IF THIS PRODUCT IS SWALLOWED, IRRITATION OF THE MOUTH,
THROAT, ESOPHAGUS AND OTHER TISSUES OF THE DIGESTIVE SYSTEM MAY OCCUR.
SYMPTOMS OF INGESTION MAY INCLUDE NAUSEA, VOMITING, AND DIARRHEA.
INJECTION:
ACCIDENTAL INJECTION OF THIS PRODUCT, VIA LACERATION OR PUNCTURE BY A
CONTAMINATED OBJECT CAN CAUSE REDNESS AT THE SITE OF INJECTION.
HEALTH EFFECTS OR RISKS FROM EXPOSURE:
EXPOSURE TO THIS PRODUCT MAY CAUSE THE FOLLOWING HEALTH EFFECTS:
ACUTE:
INHALATION OF FUMES OR VAPORS MAY CAUSE IRRITATION OF RESPIRATORY SYSTEM.
EYE CONTACT MAY CAUSE MECHANICAL IRRITATION. EYE CONTACT WITH FUMES CAN
CAUSE IRRITATION. MAY BE HARMFUL IF SWALLOWED.
CHRONIC:
PROLONGED OR REPEATED SKIN EXPOSURE MAY CAUSE DERMATITIS (DRY RED SKIN).
TARGET ORGANS:
ACUTE: SKIN, EYES, RESPIRATORY SYSTEM.
CHRONIC: SKIN.
TOXICITY DATA:
CURRENTLY, THE FOLLOWING TOXICOLOGICAL DATA ARE AVAILABLE FOR COMPONENTS
OF 1% OR MORE CONCENTRATION.
ALUMINUM TRIHYDRATE:
TDLO (ORAL-CHILD):
79 GM/KG/2 YEARS-INTERMITTENT:
BEHAVIORAL:
CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY), MUSCLE CONTRACTION OR
SPASTICITY
MUSCULOSKELETAL: OSTEOMALACIA
TDLO (ORAL-CHILD):
122 GM/KG/4 DAYS:
GASTROINTESTINAL: OTHER CHANGES
NUTRITIONAL AND GROSS METABOLIC: BODY TEMPERATURE INCREASE
TDLO (ORAL-WOMAN):
84 GM/KG:
FEMALE 1-40 WEEK(S) AFTER CONCEPTION:
REPRODUCTIVE:
EFFECTS ON NEWBORN: PHYSICAL
TDLO (ORAL-INFANT):
68040 MG/KG/24 WEEKS-INTERMITTENT:
MUSCULOSKELETAL: OSTEOPOROSIS
NUTRITIONAL AND GROSS METABOLIC:
WEIGHT LOSS OR DECREASED WEIGHT GAIN, CHANGES IN PHOSPHORUS
TDLO (ORAL-WOMAN):
73912.5 MG/KG/26 WEEKS-INTERMITTENT:
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
MUSCULOSKELETAL: OSTEOPOROSIS
NUTRITIONAL AND GROSS:
METABOLIC: CHANGES IN PHOSPHORUS
TDLO (UNREPORTED-INFANT):
39 GM/KG/24 DAYS-INTERMITTENT:
MUSCULOSKELETAL: OSTEOMALACIA
TDLO (ORAL-RAT):
15 MG/KG:
GASTROINTESTINAL: OTHER CHANGES
TDLO (ORAL-RAT):
8040 MG/KG/67 DAYS-CONTINUOUS:
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
NUTRITIONAL AND GROSS METABOLIC: CHANGES IN PHOSPHORUS
TDLO (ORAL-MOUSE):
80,880 MG/KG/23 WEEKS-CONTINUOUS:
LIVER: OTHER CHANGES
MUSCULOSKELETAL: OTHER CHANGES
NUTRITIONAL AND GROSS METABOLIC: CHANGES IN METALS, NOT OTHERWISE SPECIFIED
TDLO (INTRAPERITONEAL-RAT): 150 MG/KG
TDLO (INTRAPERITONEAL-RAT):
6240 MG/KG/26 WEEKS-INTERMITTENT:
BLOOD: PIGMENTED OR NUCLEATED RED BLOOD CELLS
NUTRITIONAL AND GROSS METABOLIC:
WEIGHT LOSS OR DECREASED WEIGHT GAIN, CHANGES IN IRON
TDLO (INTRAPERITONEAL-RAT):
1920 MG/KG/8 WEEKS-INTERMITTENT:
BLOOD: MICROCYTOSIS WITH OR WITHOUT ANEMIA
TDLO (INTRAPERITONEAL-RAT):
960 MG/KG/4 WEEKS-INTERMITTENT:
BLOOD: CHANGES IN ERYTHROCYTE (RBC) COUNT
TDLO (ORAL-CHILD):
79 GM/KG/2 YEARS-INTERMITTENT:
BEHAVIORAL:
CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY), MUSCLE CONTRACTION OR
SPASTICITY
MUSCULOSKELETAL: OSTEOMALACIA
TDLO (ORAL-CHILD):
122 GM/KG/4 DAYS:
GASTROINTESTINAL: OTHER CHANGES
NUTRITIONAL AND GROSS METABOLIC: BODY TEMPERATURE INCREASE
TDLO (ORAL-WOMAN):
84 GM/KG:
FEMALE 1-40 WEEK(S) AFTER CONCEPTION:
REPRODUCTIVE:
EFFECTS ON NEWBORN: PHYSICAL
TDLO (ORAL-INFANT):
68040 MG/KG/24 WEEKS-INTERMITTENT:
MUSCULOSKELETAL: OSTEOPOROSIS
NUTRITIONAL AND GROSS METABOLIC:
WEIGHT LOSS OR DECREASED WEIGHT GAIN, CHANGES IN PHOSPHORUS
TDLO (ORAL-WOMAN):
73912.5 MG/KG/26 WEEKS-INTERMITTENT:
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
MUSCULOSKELETAL: OSTEOPOROSIS
NUTRITIONAL AND GROSS:
METABOLIC: CHANGES IN PHOSPHORUS
TDLO (UNREPORTED-INFANT):
39 GM/KG/24 DAYS-INTERMITTENT:
MUSCULOSKELETAL: OSTEOMALACIA
TDLO (ORAL-RAT):
15 MG/KG:
GASTROINTESTINAL: OTHER CHANGES
TDLO (ORAL-RAT):
8040 MG/KG/67 DAYS-CONTINUOUS:
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
NUTRITIONAL AND GROSS METABOLIC: CHANGES IN PHOSPHORUS
TDLO (ORAL-MOUSE):
80,880 MG/KG/23 WEEKS-CONTINUOUS:
LIVER: OTHER CHANGES
MUSCULOSKELETAL: OTHER CHANGES
NUTRITIONAL AND GROSS METABOLIC: CHANGES IN METALS, NOT OTHERWISE SPECIFIED
TDLO (INTRAPERITONEAL-RAT): 150 MG/KG
TDLO (INTRAPERITONEAL-RAT):
6240 MG/KG/26 WEEKS-INTERMITTENT:
BLOOD: PIGMENTED OR NUCLEATED RED BLOOD CELLS
NUTRITIONAL AND GROSS METABOLIC:
WEIGHT LOSS OR DECREASED WEIGHT GAIN, CHANGES IN IRON
TDLO (INTRAPERITONEAL-RAT):
1920 MG/KG/8 WEEKS-INTERMITTENT:
BLOOD: MICROCYTOSIS WITH OR WITHOUT ANEMIA
TDLO (INTRAPERITONEAL-RAT):
960 MG/KG/4 WEEKS-INTERMITTENT:
BLOOD:
CHANGES IN ERYTHROCYTE (RBC) COUNT
PHENOL:
LDLO (ORAL-HUMAN):
14 GM/KG:
BEHAVIORAL: MUSCLE WEAKNESS
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
LDLO (ORAL-HUMAN):
140 MG/KG:
BEHAVIORAL: HALLUCINATIONS, DISTORTED PERCEPTIONS
SKIN AND APPENDAGES: SWEATING
LDLO (ORAL-INFANT):
10 MG/KG:
BEHAVIORAL: MUSCLE WEAKNESS
LUNGS, THORAX, OR RESPIRATION: CYANOSIS
TDLO (PARENTERAL-MAN):
105.3 MG/KG:
PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
KIDNEY/URETER/BLADDER: RENAL FUNCTION TESTS DEPRESSED
TDLO (UNREPORTED-MAN):
5714 (MICRO)G/KG:
SENSE ORGANS AND SPECIAL SENSES (OLFACTION):
EFFECT, NOT OTHERWISE SPECIFIED
IC50 (IN VITRO-HUMAN LIVER):
3.02 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC
IC50 (IN VITRO-HUMAN LIVER):
9.67 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC
IC50 (IN VITRO-HUMAN LIVER TUMOR):
10 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES: CELL PROTEIN SYNTHESIS
IC50 (IN VITRO-HUMAN LIVER TUMOR):
3.47 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY:
CYTOPLASMIC ENZYMES LEAKAGE (LACTATE DEHYDROGENASE, ATP ENZYMES ETC.), CELL
VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS): MTT, XTT, MTS, WSTS ASSAYS ETC
IC50 (IN VITRO-HUMAN LIVER TUMOR):
14.66 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY:
CYTOPLASMIC ENZYMES LEAKAGE (LACTATE DEHYDROGENASE, ATP ENZYMES ETC.), CELL
VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS): MTT, XTT, MTS, WSTS ASSAYS ETC
IC50 (IN VITRO-HUMAN HELA CELL):
100 MG/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY:
CYTOPLASMIC ENZYMES LEAKAGE (LACTATE DEHYDROGENASE, ATP ENZYMES ETC.)
OPEN IRRITATION TEST (SKIN-RABBIT):
535 MG: SEVERE
STANDARD DRAIZE TEST (SKIN-RABBIT):
100 MG: MILD
STANDARD DRAIZE TEST (EYE-RABBIT):
5 MG: SEVERE
STANDARD DRAIZE TEST (EYE-RABBIT):
400 (MICRO)L/30 SECONDS: SEVERE
RINSED WITH WATER (EYE-RABBIT):
5 MG/30 SECONDS: MILD
LC50 (INHALATION-RAT): 316 MG/M3
LC50 (INHALATION-RAT): 316 MG/M3/4 HOURS
LC50 (INHALATION-MOUSE): 177 MG/M3
LC50 (INHALATION-MOUSE): 177 MG/M3/4 HOURS
LD50 (ORAL-RAT):
317 MG/KG:
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LD50 (ORAL-RAT): 512 MG/KG
LD50 (ORAL-MOUSE): 270 MG/KG
LD50 (ORAL-MAMMAL-SPECIES UNSPECIFIED): 500 MG/KG
LD50 (SKIN-RAT): 1500 MG/KG
LD50 (SKIN-RAT):
669 MG/KG:
BEHAVIORAL: TREMOR
KIDNEY/URETER/BLADDER: HEMATURIA
SKIN AND APPENDAGES:
CUTANEOUS SENSITIZATION, EXPERIMENTAL (AFTER TOPICAL EXPOSURE)
LD50 (SKIN-RABBIT): 630 MG/KG
LD50 (INTRAPERITONEAL-RAT): 127 MG/KG
LD50 (INTRAPERITONEAL-MOUSE): 180 MG/KG
LD50 (SUBCUTANEOUS-RAT): 300 MG/KG
LD50 (SUBCUTANEOUS-MOUSE): 344 MG/KG
LD50 (INTRAVENOUS-MOUSE):
112 MG/KG:
BEHAVIORAL: TREMOR
IC10 (IN VITRO-RAT LIVER):
1.12 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY:
CYTOPLASMIC ENZYMES LEAKAGE (LACTATE DEHYDROGENASE, ATP ENZYMES ETC.), CELL
VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS): MTT, XTT, MTS, WSTS ASSAYS ETC
IC10 (IN VITRO-RAT LUNG):
0.03 GM/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY (PRELABELED CELLS):
RELEASE OF RADIOACTIVE ISOTOPES ([51CR], [3H]-THYMIDINE, [3H]-PROLINE,
[35S]- OR [75SE]-METHIONINE, 5-[125I]-2-DEOXY-URIDINE) OR FLUORESCENT DYES
(BIS-CARBOXYETHYL-CARBOXYFLUORESCEIN (BCECF) OR CALCEIN-AM) TIVIEQ
IC10 (IN VITRO-RAT LUNG):
0.2 GM/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC
IC10 (IN VITRO-CHICKEN NEURONS):
7470 (MICRO)MOL/L/21 HOUR.....IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC
IC10 (IN VITRO-CHICKEN NEURONS):
1862 (MICRO)MOL/L/21 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC
IC10 (IN VITRO-CHICKEN NEURONS):
614 (MICRO)MOL/L/20 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (LYSOSOMAL DAMAGE): NEUTRAL RED ASSAY ETC.
IC50 (IN VITRO-RAT LIVER):
3.3 MMOL/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY:
CYTOPLASMIC ENZYMES LEAKAGE (LACTATE DEHYDROGENASE, ATP ENZYMES ETC.), CELL
VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS): MTT, XTT, MTS, WSTS ASSAYS ETC.
IC50 (IN VITRO-RAT LUNG):
1 GM/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL VIABILITY (MITOCHONDRIAL REDUCTASE ASSAYS):
MTT, XTT, MTS, WSTS ASSAYS ETC.
IC50 (IN VITRO-RAT LUNG):
0.36 GM/L/24 HOURS:
IN VITRO TOXICITY STUDIES:
CELL MEMBRANE INTEGRITY (PRELABELED CELLS):
RELEASE OF RADIOACTIVE ISOTOPES ([51CR], [3H]-THYMIDINE, [3H]-PROLINE,
[35S]- OR [75SE]-METHIONINE, 5-[125I]-2-DEOXY-URIDINE) OR FLUORESCENT DYES
(BIS-CARBOXYETHYL-CARBOXYFLUORESCEIN (BCECF) OR CALCEIN-AM)
TDLO (ORAL-MOUSE):
2800 MG/KG/10 DAYS-INTERMITTENT:
BEHAVIORAL: TREMOR, ATAXIA
TDLO (SKIN-MOUSE):
329 MG/KG/30 MINUTES:
SKIN AND APPENDAGES: PRIMARY IRRITATION (AFTER TOPICAL EXPOSURE)
BIOCHEMICAL:
METABOLISM (INTERMEDIARY):
OTHER, EFFECT ON INFLAMMATION OR MEDIATION OF INFLAMMATION
TDLO (SKIN-MOUSE):
88.9 (MICRO)L/KG:
BIOCHEMICAL:
METABOLISM (INTERMEDIARY):
EFFECT ON INFLAMMATION OR MEDIATION OF INFLAMMATION
TDLO (SKIN-MOUSE):
16 GM/KG/40 WEEKS-INTERMITTENT:
TUMORIGENIC: CARCINOGENIC BY RTECS CRITERIA
SKIN AND APPENDAGES: TUMORS
TDLO (INTRAPERITONEAL-RAT):
650 MG/KG/17 DAYS-INTERMITTENT:
BLOOD: OTHER CHANGES
TDLO (INTRAPERITONEAL-RAT):
600 MG/KG:
FEMALE 12-14 DAY(S) AFTER CONCEPTION:
REPRODUCTIVE:
EFFECTS ON EMBRYO OR FETUS: FETOTOXICITY (EXCEPT DEATH, E.G., STUNTED
FETUS)
TDLO (INTRAPERITONEAL-MOUSE):
300 MG/KG:
NUTRITIONAL AND GROSS METABOLIC: BODY TEMPERATURE DECREASE
TDLO (INTRAPERITONEAL-MOUSE):
300 MG/KG:
IMMUNOLOGICAL INCLUDING ALLERGIC: HYPERSENSITIVITY DELAYED
TCLO (INHALATION-RAT):
110 MG/M3/4 HOURS:
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
BIOCHEMICAL:
ENZYME INHIBITION, INDUCTION, OR CHANGE IN BLOOD OR TISSUE LEVELS:
PROTEASES
TCLO (INHALATION-RAT):
150 UG/M3/8 HOURS/26 WEEKS-INTERMITTENT:
KIDNEY/URETER/BLADDER:
CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)
BIOCHEMICAL:
ENZYME INHIBITION, INDUCTION, OR CHANGE IN BLOOD OR TISSUE LEVELS:
PHOSPHATASES
TCLO (INHALATION-RAT):
5 MG/M3/4 HOURS/17 WEEKS-INTERMITTENT:
LIVER: LIVER FUNCTION TESTS IMPAIRED
ENDOCRINE: EFFECT ON MENSTRUAL CYCLE
BLOOD: CHANGES IN LEUKOCYTE (WBC) COUNT
TCLO (INHALATION-RAT):
100 (MICRO)G/M3/24 HOURS/61 DAYS-CONTINUOUS:
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY
BLOOD: OTHER CHANGES
BIOCHEMICAL:
ENZYME INHIBITION, INDUCTION, OR CHANGE IN BLOOD OR TISSUE LEVELS:
TRUE CHOLINESTERASE
TCLO (INHALATION-RAT):
0.5 MG/M3/4 HOURS/122 DAYS-INTERMITTENT:
BLOOD: CHANGES IN SERUM COMPOSITION (E.G. TP, BILIRUBIN, CHOLESTEROL)
BIOCHEMICAL:
ENZYME INHIBITION, INDUCTION, OR CHANGE IN BLOOD OR TISSUE LEVELS:
MULTIPLE ENZYME EFFECTS
TCLO (INHALATION-MOUSE):
15 PPM/6 MINUTES:
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
LCLO (INHALATION-RAT): 232 MG/M3/4 HOURS
LCLO (INHALATION-MOUSE): 110 MG/M3/4 HOURS
MUTATION TEST SYSTEMS-NOT OTHERWISE SPECIFIED (HUMAN HELA CELL): 17 MG/L
MUTATION TEST SYSTEMS-NOT OTHERWISE SPECIFIED (HUMAN LYMPHOCYTE):
5 (MICRO)MOL/L
DNA INHIBITION (HUMAN HELA CELL): 1 MMOL/L
SISTER CHROMATID EXCHANGE (HUMAN LYMPHOCYTE): 5 (MICRO)MOL/L
CYTOGENETIC ANALYSIS (HUMAN CELLS-NOT OTHERWISE SPECIFIED):
300 (MICRO)MOL/L/30 HOURS
MUTATION IN MICROORGANISMS (BACTERIA-SA/MONE//A TYPHIMURIUM):
40 (MICRO)MOL/PLATE
MUTATION IN MICROORGANISMS (MOUSE LYMPHOCYTE): 300 MG/L
MUTATION IN MICROORGANISMS (MICROORGANISM-NOT OTHERWISE SPECIFIED):
200 MG/L/8 HOURS
SEX CHROMOSOME LOSS AND NON-DISJUNCTION (INSECT-DROSOPHILA ME/ANOGASTER
OVARY): 100 PPM
GENE CONVERSION AND MITOTIC RECOMBINATION (MOLD-ASPERGI//US NIDU/ANS):
15 (MICRO)MOL/L
DNA DAMAGE (MAMMAL-SPECIES UNSPECIFIED LYMPHOCYTE): 250 MMOL/L
MICRONUCLEUS TEST (ORAL-MOUSE): 265 MG/KG
MICRONUCLEUS TEST (INTRAPERITONEAL-MOUSE): 265 MG/KG
MICRONUCLEUS TEST (HAMSTER LUNG): 4 MMOL/L
MICRONUCLEUS TEST (HAMSTER OVARY): 175 MG/L
MICRONUCLEUS TEST (HAMSTER EMBRYO): 500 MG/L/4 HOURS
DNA INHIBITION (ORAL-MOUSE): 20 GM/KG
DNA INHIBITION (MOUSE LYMPHOCYTE): 800 (MICRO)MOL/L
DNA INHIBITION (HAMSTER LUNG): 1900 (MICRO)MOL/L
CYTOGENETIC ANALYSIS (MULTIPLE ROUTES-FISH-NOT OTHERWISE SPECIFIED):
300 NL/L
CYTOGENETIC ANALYSIS (HAMSTER OVARY): 2 GM/L
CYTOGENETIC ANALYSIS (HAMSTER EMBRYO): 100 (MICRO)MOL/L
UNSCHEDULED DNA SYNTHESIS (ORAL-RAT): 4 GM/KG
UNSCHEDULED DNA SYNTHESIS (HAMSTER EMBRYO): 3 (MICRO)MOL/L
DNA DAMAGE (MOUSE LYMPHOCYTE): 1500 (MICRO)MOL/L
MUTATION TEST SYSTEMS-NOT OTHERWISE SPECIFIED (MOUSE CELLS-NOT OTHERWISE
SPECIFIED): 2500 (MICRO)MOL/L
MUTATION TEST SYSTEMS-NOT OTHERWISE SPECIFIED (RABBIT BONE MARROW):
250 (MICRO)MOL/L
MUTATION IN MAMMALIAN SOMATIC CELLS (MOUSE LYMPHOCYTE MOUSE LYMPHOCYTE):
1890 (MICRO)MOL/L
MUTATION IN MAMMALIAN SOMATIC CELLS (HAMSTER EMBRYO): 3 MMOL/L
MORPHOLOGICAL TRANSFORMATION (HAMSTER EMBRYO): 10 (MICRO)MOL/L
SISTER CHROMATID EXCHANGE (HAMSTER OVARY): 300 MG/L
SISTER CHROMATID EXCHANGE (HAMSTER EMBRYO): 1 MMOL/L
POLYBUTENE:
TCLO (INHALATION-RAT):
700 MG/M3/7 HOURS/2 WEEKS-INTERMITTENT:
LIVER: CHANGES IN LIVER WEIGHT
NUTRITIONAL AND GROSS METABOLIC: WEIGHT LOSS OR DECREASED WEIGHT GAIN
IRRITANCY OF PRODUCT:
INHALATION OF FUMES OR VAPORS MAY CAUSE RESPIRATORY IRRITATION. EYE CONTACT
MAY CAUSE IRRITATION. EYE CONTACT WITH FUMES MAY CAUSE IRRITATION.
PROLONGED SKIN CONTACT MAY CAUSE IRRITATION.
CARCINOGENIC POTENTIAL OF COMPONENTS:
COMPONENTS OF THIS PRODUCT ARE LISTED BY AGENCIES TRACKING THE CARCINOGENIC
POTENTIAL OF CHEMICAL COMPOUNDS, AS FOLLOWS:
CRYSTALLINE SILICA:
ACGIH-TLV-A2 (SUSPECTED HUMAN CARCINOGEN); IARC-1 (CARCINOGENIC TO HUMANS);
MAK-1 (SUBSTANCES THAT CAUSE CANCER IN MAN AND CAN BE ASSUMED TO MAKE A
SIGNIFICANT CONTRIBUTION TO CANCER RISK); NIOSH-CA (POTENTIAL OCCUPATIONAL
CARCINOGEN WITH NO FURTHER CATEGORIZATION); NTP-K (KNOWN TO BE A HUMAN
CARCINOGEN)
FORMALDEHYDE:
ACGIH-TLV-A2 (SUSPECTED HUMAN CARCINOGEN); EPA-B1 (PROBABLE HUMAN
CARCINOGEN-LIMITED EVIDENCE OF CARCINOGENICITY FROM EPIDEMIOLOGICAL
STUDIES), IARC-1 (CARCINOGENIC TO HUMANS); MAK-4 (SUBSTANCES WITH
CARCINOGENIC POTENTIAL FOR WHICH GENOTOXICITY PLAYS NO OR AT MOST A MINOR
ROLE. NO SIGNIFICANT CONTRIBUTION TO HUMAN CANCER RISK IS EXPECTED,
PROVIDED THE MAK VALUE IS OBSERVED.); NIOSH-CA (POTENTIAL OCCUPATIONAL
CARCINOGEN WITH NO FURTHER CATEGORIZATION); NTP-K (KNOWN TO BE A HUMAN
CARCINOGEN); OSHA-CA (CARCINOGEN DEFINED WITH NO FURTHER CATEGORIZATION)
PHENOL:
ACGIH TLV-A4 (NOT CLASSIFIABLE AS A HUMAN CARCINOGEN); EPA-I (DATA ARE
INADEQUATE FOR AN ASSESSMENT OF HUMAN CARCINOGENIC POTENTIAL); EPA-D (NOT
CLASSIFIABLE AS TO HUMAN CARCINOGENICITY); IARC-3 (UNCLASSIFIABLE AS TO
CARCINOGENICITY IN HUMANS); MAK-3B (SUBSTANCES FOR WHICH IN VITRO TESTS OR
ANIMAL STUDIES HAVE YIELDED EVIDENCE OF CARCINOGENIC EFFECTS THAT IS NOT
SUFFICIENT FOR CLASSIFICATION OF THE SUBSTANCE IN ONE OF THE OTHER
CATEGORIES. FURTHER STUDIES ARE REQUIRED BEFORE A FINAL CLASSIFICATION CAN
BE MADE.)
THE REMAINING COMPONENTS ARE NOT FOUND ON THE FOLLOWING LISTS:
U.S. EPA, U.S. NTP, U.S. OSHA, U.S. NIOSH, GERMAN MAK, IARC, OR ACGIH AND
THEREFORE IS NEITHER CONSIDERED TO BE NOR SUSPECTED TO BE A CANCER-CAUSING
AGENT BY THESE AGENCIES.
REPRODUCTIVE TOXICITY INFORMATION:
THIS PRODUCT IS NOT EXPECTED OR REPORTED TO CAUSE HUMAN MUTAGENIC,
EMBRYOTOXIC, TERATOGENIC OR REPRODUCTIVE TOXICITY EFFECTS. THE FOLLOWING
GIVES INFORMATION ON POSSIBLE EFFECTS FROM COMPONENTS.
MUTAGENICITY:
FORMALDEHYDE IS CONSIDERED MUTAGENIC, BASED ON POSITIVE RESULTS (E.G.
CHROMOSOMAL ABERRATIONS IN LUNG CELLS) OBSERVED IN STUDIES WITH LIVE
ANIMALS. IN OCCUPATIONAL EXPOSURE STUDIES, WHICH ARE LIMITED BY SUCH
PROBLEMS AS LOW NUMBERS OF WORKERS STUDIED AND MIXED EXPOSURES, BOTH
POSITIVE AND NEGATIVE RESULTS (MICRONUCLEI, SISTER CHROMATID EXCHANGES
(SCES), CHROMOSOME ABERRATIONS IN LYMPHOCYTES OR CHEEK AND NOSE CELLS) AND
A NEGATIVE RESULT (ABNORMAL SPERM) WERE OBTAINED.(19,44,46,81) HOWEVER,
POSITIVE RESULTS (SCES IN LYMPHOCYTES, DNA-PROTEIN CROSSLINKS IN
LYMPHOCYTES) WERE OBTAINED IN 2 REASONABLY WELL-CONDUCTED STUDIES.
EMBRYOTOXICITY/TERATOGENICITY:
NO COMPONENT IS KNOWN TO CAUSE HUMAN EMBRYOTOXICITY OR TERATOGENICITY.
ANIMAL STUDIES ARE INCONCLUSIVE OR HAVE NOT SHOWN EMBRYOTOXICITY OR
TERATOGENICITY.
REPRODUCTIVE TOXICITY:
THERE IS INSUFFICIENT EVIDENCE TO DETERMINE IF FORMALDEHYDE CAUSES
REPRODUCTIVE TOXICITY IN HUMANS. DESPITE LIMITATIONS, THE FEW ANIMAL
STUDIES AVAILABLE DO NOT SUGGEST THAT FORMALDEHYDE EXPOSURE WILL AFFECT
FERTILITY.
ACGIH BIOLOGICAL EXPOSURE INDICES (BEIS):
CURRENTLY, THERE ARE NO ACGIH BIOLOGICAL EXPOSURE INDICES (BEIS) DETERMINED
FOR THIS MATERIAL.
DEGREE OF EFFECT TO THE HEALTH OF THE POLLUTING AGENT OF ENVIRONMENT OF
WORK (PER MEXICAN NOM-010 STPS-1999): 0
| 12. ECOLOGICAL INFORMATION | |
ALL WORK PRACTICES MUST BE AIMED AT ELIMINATING ENVIRONMENTAL
CONTAMINATION.
MOBILITY: THIS PRODUCT HAS NOT BEEN TESTED FOR MOBILITY IN SOIL.
PERSISTENCE AND BIODEGRADABILITY:
THIS PRODUCT HAS NOT BEEN TESTED FOR PERSISTENCE OR BIODEGRADABILITY. THE
MINERAL COMPONENTS ARE NOT EXPECTED TO BIODEGRADE TO GREAT EXTENT.
BIO-ACCUMULATION POTENTIAL:
THIS PRODUCT HAS NOT BEEN TESTED FOR BIO-ACCUMULATION POTENTIAL.
ECOTOXICITY:
THIS PRODUCT HAS NOT BEEN TESTED FOR AQUATIC OR ANIMAL TOXICITY. ALL
RELEASES TO TERRESTRIAL, ATMOSPHERIC AND AQUATIC ENVIRONMENTS SHOULD BE
AVOIDED.
OTHER ADVERSE EFFECTS:
THIS MATERIAL IS NOT LISTED AS HAVING OZONE DEPLETION POTENTIAL.
ENVIRONMENTAL EXPOSURE CONTROLS:
CONTROLS SHOULD BE ENGINEERED TO PREVENT RELEASE TO THE ENVIRONMENT,
INCLUDING PROCEDURES TO PREVENT SPILLS, ATMOSPHERIC RELEASE AND RELEASE TO
WATERWAYS.
| 13. DISPOSAL CONSIDERATIONS | |
DISPOSAL METHODS:
IT IS THE RESPONSIBILITY OF THE GENERATOR TO DETERMINE AT THE TIME OF
DISPOSAL WHETHER THE PRODUCT MEETS THE CRITERIA OF A HAZARDOUS WASTE PER
REGULATIONS OF THE AREA IN WHICH THE WASTE IS GENERATED AND/OR DISPOSED OF.
WASTE DISPOSAL MUST BE IN ACCORDANCE WITH APPROPRIATE FEDERAL, STATE,
NATIONAL, INTERNATIONAL, AND LOCAL REGULATIONS. THIS PRODUCT, IF UNALTERED
BY USE, MAY BE DISPOSED OF BY TREATMENT AT A PERMITTED FACILITY OR AS
ADVISED BY YOUR LOCAL HAZARDOUS WASTE REGULATORY AUTHORITY. SHIPMENT OF
WASTES MUST BE DONE WITH APPROPRIATELY PERMITTED AND REGISTERED
TRANSPORTERS.
DISPOSAL CONTAINERS:
WASTE MATERIALS MUST BE PLACED IN AND SHIPPED IN APPROPRIATE 5-GALLON OR
55-GALLON POLY OR METAL WASTE PAILS OR DRUMS. ENSURE THAT ANY REQUIRED
MARKING OR LABELING OF THE CONTAINERS BE DONE TO ALL APPLICABLE
REGULATIONS.
PRECAUTIONS TO BE FOLLOWED DURING WASTE HANDLING:
WEAR PROPER PROTECTIVE EQUIPMENT WHEN HANDLING WASTE MATERIALS.
U.S. EPA WASTE NUMBER: NOT APPLICABLE.
| 14. TRANSPORTATION INFORMATION | |
U.S. DEPARTMENT OF TRANSPORTATION REGULATIONS:
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS, PER U.S. DOT
REGULATIONS, UNDER 49 CFR 172.101.
TRANSPORT CANADA TRANSPORTATION OF DANGEROUS GOODS REGULATIONS:
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS, PER REGULATIONS OF
TRANSPORT CANADA.
INTERNATIONAL AIR TRANSPORT ASSOCIATION (IATA):
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS UNDER RULES OF IATA.
INTERNATIONAL MARITIME ORGANIZATION (IMO) DESIGNATION:
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS BY THE INTERNATIONAL
MARITIME ORGANIZATION.
OFFICIAL MEXICAN STANDARD; REGULATION FOR THE TRANSPORT OF DANGEROUS GOODS
AND RESIDUES:
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS, PER TRANSPORT
REGULATIONS OF MEXICO.
SINGAPORE STANDARD 286:
PART A:
THIS PRODUCT HAS NO REQUIREMENTS UNDER THE SPECIFICATION FOR CAUTION
LABELING FOR HAZARDOUS SUBSTANCES
PART 4:
MARKING OF PACKAGES, CONTAINERS AND VEHICLES, AS IT DOES NOT MEET THE
CRITERIA FOR ANY HAZARD CLASS UNDER THIS REGULATION.
TRANSPORT IN BULK ACCORDING TO THE IBC CODE:
SEE THE INFORMATION UNDER THE INDIVIDUAL JURISDICTION LISTINGS FOR IBC
INFORMATION.
ENVIRONMENTAL HAZARDS:
THIS MATERIAL DOES NOT MEET THE CRITERIA OF ENVIRONMENTALLY HAZARDOUS
ACCORDING TO THE CRITERIA OF THE UN MODEL REGULATIONS (AS REFLECTED IN THE
IMDG CODE, ADR, RID, AND ADN) AND IS NOT LISTED IN ANNEX III UNDER MARPOL
73/78.
| 15. REGULATORY INFORMATION | |
UNITED STATES REGULATIONS:
U.S. SARA REPORTING REQUIREMENTS:
THE COMPONENTS OF THIS PRODUCT ARE SUBJECT TO THE REPORTING REQUIREMENTS OF
SECTIONS 302, 304, AND 313 OF TITLE III OF THE SUPERFUND AMENDMENTS AND
REAUTHORIZATION ACT AS FOLLOWS.
CHEMICAL NAME SARA 302 SARA 304 SARA 313
(40 CFR 355, (40 CFR TABLE (40 CFR 372.65)
APPENDIX A) 302.4)
FORMALDEHYDE YES YES YES
PHENOL YES YES YES
U.S. SARA HAZARD CATEGORIES (SECTION 311/312, 40 CFR 370-21):
ACUTE: YES
CHRONIC: YES
FIRE: NO
REACTIVE: NO
SUDDEN RELEASE: NO
U.S. SARA THRESHOLD PLANNING QUANTITY (TPQ):
FORMALDEHYDE: 500 LB (27.2 KG)
PHENOL: 500 LB (27.2 KG)
U.S. CERCLA REPORTABLE QUANTITY (RQ):
FORMALDEHYDE: 100 LB (45.4 KG)
PHENOL: 1000 LB (454 KG)
U.S. TSCA INVENTORY STATUS:
COMPONENTS OF THIS PRODUCT ARE LISTED ON THE TSCA INVENTORY.
CALIFORNIA SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT (PROPOSITION 65):
THE CRYSTALLINE SILICA AND FORMALDEHYDE (GAS) COMPONENTS ARE ON THE
CALIFORNIA PROPOSITION 65 LISTS.
WARNING!
THIS PRODUCT CONTAINS COMPOUNDS KNOWN TO THE STATE OF CALIFORNIA TO CAUSE
CANCER. THIS PRODUCT CONTAINS TRACE AMOUNTS OF A SUSPECTED HUMAN CARCINOGEN
BY INHALATION; HOWEVER, THIS HAZARD IS NOT EXPECTED TO BE SIGNIFICANT DUE
TO VISCOSITY AND CONSISTENCY OF THE MIXTURE.
CANADIAN REGULATIONS:
CANADIAN DSL/NDSL INVENTORY STATUS:
COMPONENTS ARE ON THE DSL OR NDSL INVENTORIES.
CANADIAN ENVIRONMENTAL PROTECTION ACT (CEPA) PRIORITIES SUBSTANCES LISTS:
THE PHENOL AND FORMALDEHYDE COMPONENTS ARE ON THE CEPA PRIORITIES
SUBSTANCES 2 LIST.
CANADIAN WHMIS CLASSIFICATION AND SYMBOLS:
THIS PRODUCT WOULD BE CATEGORIZED AS A CONTROLLED PRODUCT, D2B (OTHER TOXIC
EFFECTS-POTENTIAL CARCINOGENIC AND MUTAGENIC EFFECT, IRRITATION, SKIN
SENSITIZATION) AS PER THE CONTROLLED PRODUCT REGULATIONS.
D2 - MATERIALS CAUSING OTHER TOXIC EFFECTS
CHINESE REGULATIONS:
CHINESE INVENTORY OF EXISTING CHEMICAL SUBSTANCES STATUS:
COMPONENTS LISTED BY CAS# ARE LISTED ON THE CHINESE INVENTORY OF EXISTING
CHEMICAL SUBSTANCES (IECSC), OR ARE NOT LISTED, PER INFORMATION IN SECTION
2.
JAPANESE REGULATIONS:
JAPANESE ENCS:
COMPONENTS LISTED BY CAS# ARE ON THE ENCS INVENTORY, ARE EXCEPTED, OR ARE
NOT LISTED, PER INFORMATION IN SECTION 2.
JAPANESE MINISTRY OF ECONOMY, TRADE, AND INDUSTRY (METI) STATUS:
COMPONENTS ARE NOT LISTED AS CLASS I SPECIFIED CHEMICAL SUBSTANCES, CLASS
II SPECIFIED CHEMICAL SUBSTANCES, OR DESIGNATED CHEMICAL SUBSTANCES BY THE
JAPANESE METI.
POISONOUS AND DELETERIOUS SUBSTANCES CONTROL LAW:
COMPONENTS ARE NOT LISTED AS A SPECIFIED POISONOUS SUBSTANCE UNDER THE
POISONOUS AND DELETERIOUS SUBSTANCES CONTROL LAW.
KOREAN REGULATIONS:
KOREAN EXISTING CHEMICALS LIST (ECL) STATUS:
COMPONENTS LISTED BY CAS# ARE LISTED ON THE KOREAN ECL INVENTORY, OR ARE
NOT LISTED, PER INFORMATION IN SECTION 2.
MEXICAN REGULATIONS:
MEXICAN WORKPLACE REGULATIONS (NOM-018-STPS-2000):
THIS PRODUCT IS CLASSIFIED AS HAZARDOUS.
SINGAPORE REGULATIONS:
LIST OF CONTROLLED HAZARDOUS SUBSTANCES:
COMPONENTS LISTED BY CAS# ARE NOT LISTED ON THE SINGAPORE LIST OF
CONTROLLED SUBSTANCES.
CODE OF PRACTICE ON POLLUTION CONTROL REQUIREMENTS:
THE COMPONENTS IDENTIFIED BY CAS# IN SECTION 2 (COMPOSITION AND INFORMATION
ON INGREDIENTS) NOT ARE SUBJECT TO THE REQUIREMENTS UNDER THE SINGAPORE
CODE OF PRACTICE ON POLLUTION CONTROL.
TAIWANESE REGULATIONS:
TAIWAN EXISTING CHEMICAL SUBSTANCES INVENTORY STATUS:
COMPONENTS LISTED BY CAS# ARE LISTED ON THE TAIWAN EXISTING CHEMICALS LIST.
| 16. OTHER INFORMATION | |
REVISION DETAILS: NEW.
REFERENCES AND DATA SOURCES: CONTACT THE SUPPLIER FOR INFORMATION.
METHODS OF EVALUATING INFORMATION FOR THE PURPOSE OF CLASSIFICATION:
CRITERIA OF THE GHS WERE USED FOR CLASSIFICATION.
PREPARED BY:
CHEMICAL SAFETY ASSOCIATES, INC.
PO BOX 1961
HILO, HI 96721-1961
(800) 441 -3365
DATE OF PRINTING: JUNE 13, 2016
REVISION HISTORY: NEW.
STI MARINE FIRESTOP PUTTY (MPU) SDS
EFFECTIVE DATE: JUNE 13, 2016
SPECSEAL(R*) FIRESTOP PUTTY SDS
EFFECTIVE DATE: JANUARY 4, 2015